{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:55:53Z","timestamp":1785390953806,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-018-3661-0","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:43:08Z","timestamp":1546821788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4791-3133","authenticated-orcid":false,"given":"Raimonda","family":"Matulionyt\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u0119stutis","family":"\u017dagminas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egl\u0117","family":"Bal\u010di\u016bnait\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017ebieta","family":"Matulyt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasut\u0117","family":"Paulauskien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almina","family":"Bajori\u016bnien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvydas","family":"Ambrozaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"3661_CR1","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe (2017) HIV\/AIDS surveillance in Europe 2016. Available from: \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/20171127-Annual_HIV_Report_Cover%2BInner.pdf"},{"key":"3661_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001510","volume":"10","author":"A Mocroft","year":"2013","unstructured":"Collaboration of observational HIV epidemiological research Europe (COHERE) study in EuroCoord, Mocroft A, Lundgren JD, Sabin ML, Ad M, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PLoS Med. 2013;10:e1001510.","journal-title":"PLoS Med"},{"key":"3661_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140845","volume":"10","author":"D Raben","year":"2015","unstructured":"Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, et al. HIDES audit study group. Auditing HIV testing rates across Europe: results from the HIDES 2 study. PLoS One. 2015;10:e0140845.","journal-title":"PLoS One"},{"key":"3661_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041673","volume":"7","author":"J Reekie","year":"2012","unstructured":"Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, et al. EuroSIDA in EuroCoord. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One. 2012;7:e41673.","journal-title":"PLoS One"},{"key":"3661_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijid.2018.03.007","volume":"70","author":"D Gokengin","year":"2018","unstructured":"Gokengin D, Oprea C, Begovac J, Horban A, Zeka AN, Sedlacek D, et al. HIV care in central and Eastern Europe: how close are we to the target? Int J Infect Dis. 2018;70:121\u201330.","journal-title":"Int J Infect Dis"},{"key":"3661_CR6","unstructured":"European Centre for Disease Prevention and Control (2016) HIV\/AIDS WHO regional Office for Europe. HIV\/AIDS surveillance in Europe 2015. Available from: \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/HIV-AIDS-surveillance-Europe-2015.pdf"},{"key":"3661_CR7","unstructured":"European Centre for Disease Prevention and Control (2015) HIV\/AIDS WHO regional Office for Europe. HIV\/AIDS surveillance in Europe 2014. Available from: \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/hiv-aids-surveillance-in-Europe-2014.pdf"},{"key":"3661_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/eurpub\/ckp231","volume":"20","author":"J Deblonde","year":"2010","unstructured":"Deblonde J, De Koker P, Hamers FF, Fontaine J, Luchters S, Temmerman M. Barriers to HIV testing in Europe: a systematic review. Eur J Pub Health. 2010;20:422\u201332.","journal-title":"Eur J Pub Health"},{"key":"3661_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/hiv.12480","volume":"18","author":"RS Drew","year":"2017","unstructured":"Drew RS, Rice B, R\u00fc\u00fctel K, Delpech V, Attawell KA, Hales DK, et al. HIV continuum of care in Europe and Central Asia. HIV Med. 2017;18:490\u20139.","journal-title":"HIV Med"},{"key":"3661_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-13-200","volume":"13","author":"K Champenois","year":"2013","unstructured":"Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E. Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis. 2013;13:200.","journal-title":"BMC Infect Dis"},{"key":"3661_CR11","unstructured":"UNAIDS. AIDSinfo. Lithuania: People living with HIV: HIV prevalence. Available from: \n                    http:\/\/aidsinfo.unaids.org\/"},{"key":"3661_CR12","unstructured":"The Action plan for HIV\/AIDS and STI Prevention and Control 2018\u20132020. Ministry of Health of the Republic of Lithuania. TAR, Apr 24, 2018, No 6521. Available from: \n                    https:\/\/www.e-tar.lt\/portal\/en\/legalAct\/1775390047ae11e8ade598b2394a491d"},{"key":"3661_CR13","unstructured":"UNAIDS. Country Progress Report: Lithuania. 2015. Available from: \n                    http:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/LTU_narrative_report_2015.pdf"},{"key":"3661_CR14","volume-title":"Increasing uptake and effectiveness in the European Union","author":"European Centre for Disease Prev Control HIV testing","year":"2010","unstructured":"European Centre for Disease Prev Control HIV testing. Increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2010. Available from: \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/101129_GUI_HIV_testing.pdf"},{"key":"3661_CR15","volume-title":"Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union","author":"European Centre for Disease Prev Control HIV testing in Europe","year":"2016","unstructured":"European Centre for Disease Prev Control HIV testing in Europe. Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2016. Available from: \n                    https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/HIV-testing-guidance-evaluation.pdf"},{"key":"3661_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMsa042088","volume":"352","author":"AD Paltiel","year":"2005","unstructured":"Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, et al. Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med. 2005;352:586\u201395.","journal-title":"N Engl J Med"},{"key":"3661_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/QAI.0b013e3182a21611","volume":"64","author":"MS Lyons","year":"2013","unstructured":"Lyons MS, Lindsell CJ, Ruffner AH, Wayne DB, Hart KW, Sperling MI, et al. Randomized comparison of universal and targeted HIV screening in the emergency department. J Acquir Immune Defic Syndr. 2013;64:315\u201323.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3661_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013132","volume":"5","author":"Y Yazdanpanah","year":"2010","unstructured":"Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, et al. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One. 2010;5:e13132.","journal-title":"PLoS One"},{"key":"3661_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084173","volume":"8","author":"Y Yazdanpanah","year":"2013","unstructured":"Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, et al. Routine HIV screening in Portugal: clinical impact and cost-effectiveness. PLoS One. 2013;8:e84173.","journal-title":"PLoS One"},{"key":"3661_CR20","first-page":"1","volume":"55","author":"BM Branson","year":"2006","unstructured":"Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1\u201317.","journal-title":"MMWR Recomm Rep"},{"key":"3661_CR21","unstructured":"Raben D, Sullivan A, Salminen M, Delpech V, Radcliffe K, Sabin ML, et al. Panel on Guidance on Indicator Condition-Guided HIV testing in Adults. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. 2012. Awailable from: \n                    http:\/\/hiveurope.eu\/Portals\/0\/Guidance.pdf.pdf\n                    \n                  ."},{"key":"3661_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052845","volume":"8","author":"AK Sullivan","year":"2013","unstructured":"Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8:e52845.","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"3661_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1468-1293.2008.00592.x","volume":"9","author":"B Gazzard","year":"2008","unstructured":"Gazzard B, Clumeck N, d'Arminio Monforte A, Lundgren JD. Indicator disease-guided testing for HIV--the next step for Europe? HIV Med. 2008;9(Suppl 2):34\u201340.","journal-title":"HIV Med."},{"issue":"Suppl 1","key":"3661_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3851\/IMP1526","volume":"15","author":"Y Yazdanpanah","year":"2010","unstructured":"Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Earlier testing for HIV--how do we prevent late presentation? Antivir Ther. 2010;15(Suppl 1):17\u201324.","journal-title":"Antivir Ther"},{"issue":"Suppl 2","key":"3661_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-1293.2008.00585.x","volume":"9","author":"S Mounier-Jack","year":"2008","unstructured":"Mounier-Jack S, Nielsen S, Coker RJ. HIV testing strategies across European countries. HIV Med. 2008;9(Suppl 2):13\u20139.","journal-title":"HIV Med."},{"key":"3661_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/hiv.12474","volume":"18","author":"C Henriquez-Camacho","year":"2017","unstructured":"Henriquez-Camacho C, Villafuerte-Gutierrez P, P\u00e9rez-Molina JA, Losa J, Gotuzzo E, Cheyne N. Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis. HIV Med. 2017;18:419\u201329.","journal-title":"HIV Med."},{"key":"3661_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046437","volume":"7","author":"E Casalino","year":"2012","unstructured":"Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E. Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study. PLoS One. 2012;7:e46437.","journal-title":"PLoS One"},{"key":"3661_CR28","doi-asserted-by":"publisher","first-page":"812.e9","DOI":"10.1016\/j.cmi.2016.06.014","volume":"22","author":"Y Dickstein","year":"2016","unstructured":"Dickstein Y, Nir-Paz R, Pulcini C, Cookson B, Beovi\u0107 B, Tacconelli E, et al. Staffing for infectious diseases, clinical microbiology and infection control in hospitals in 2015: results of an ESCMID member survey. Clin Microbiol Infect. 2016;22:812.e9\u2013812.e17.","journal-title":"Clin Microbiol Infect"},{"key":"3661_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2334-12-72","volume":"12","author":"J Wohlgemut","year":"2012","unstructured":"Wohlgemut J, Lawes T, Laing RB. Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study. BMC Infect Dis. 2012;12:72.","journal-title":"BMC Infect Dis"},{"key":"3661_CR30","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/QAD.0000000000000270","volume":"28","author":"V Supervie","year":"2014","unstructured":"Supervie V, Ndawinz JD, Lodi S, Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS. 2014;28:1797\u2013804.","journal-title":"AIDS"},{"key":"3661_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077763","volume":"8","author":"HI Hall","year":"2013","unstructured":"Hall HI, Halverson J, Wilson DP, Suligoi B, Diez M, Le Vu S. Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One. 2013;8:e77763.","journal-title":"PLoS One"},{"key":"3661_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/QAI.0000000000000589","volume":"69","author":"HI Hall","year":"2015","unstructured":"Hall HI, Song R, Szwarcwald CL, Green T. Brief report: time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr. 2015;69:248\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3661_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/sextrans-2013-051312","volume":"90","author":"R Elmahdi","year":"2014","unstructured":"Elmahdi R, Gerver SM, Gomez Guillen G, Fidler S, Cooke G, Ward H. Low levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelines. Sex Transm Infect. 2014;90:119\u201324.","journal-title":"Sex Transm Infect"},{"issue":"Suppl 3","key":"3661_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/hiv.12069","volume":"14","author":"M Rayment","year":"2013","unstructured":"Rayment M, Rae C, Ghooloo F, Doku E, Hardie J, Finlay S, et al. Routine HIV testing in the emergency department: tough lessons in sustainability. HIV Med. 2013;14(Suppl 3):6\u20139.","journal-title":"HIV Med."},{"key":"3661_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039530","volume":"7","author":"M Rayment","year":"2012","unstructured":"Rayment M, Thornton A, Mandalia S, Elam G, Atkins M, Jones R, et al. HINTS study group. HIV testing in non-traditional settings--the HINTS study: a multi-Centre observational study of feasibility and acceptability. PLoS One. 2012;7:e39530.","journal-title":"PLoS One"},{"key":"3661_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.annemergmed.2015.04.032","volume":"66","author":"EM Gardner","year":"2015","unstructured":"Gardner EM, Haukoos JS. At the crossroads of the HIV care continuum: emergency departments and the HIV epidemic. Ann Emerg Med. 2015;66:79\u201381.","journal-title":"Ann Emerg Med"},{"key":"3661_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062686","volume":"8","author":"KW d'Almeida","year":"2013","unstructured":"d'Almeida KW, Pateron D, Kierzek G, Renaud B, Semaille C, de Truchis P, et al. Understanding providers' offering and patients' acceptance of HIV screening in emergency departments: a multilevel analysis. ANRS 95008, Paris, France. PLoS One. 2013;8:e62686.","journal-title":"PLoS One"},{"key":"3661_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/OLQ.0000000000000139","volume":"41","author":"JS Haukoos","year":"2014","unstructured":"Haukoos JS, Hopkins E, Bucossi MM. Routine opt-out HIV screening: more evidence in support of alternative approaches? Sex Transm Dis. 2014;41:403\u20136.","journal-title":"Sex Transm Dis"},{"key":"3661_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7861\/clinmedicine.16-2-175","volume":"16","author":"L Bull","year":"2016","unstructured":"Bull L, Rayment M. HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented. Clin Med (Lond). 2016;16:175\u20139.","journal-title":"Clin Med (Lond)"},{"key":"3661_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/hiv.12430","volume":"18","author":"E Lord","year":"2017","unstructured":"Lord E, Stockdale AJ, Malek R, Rae C, Sperle I, Raben D, et al. British Association of Sexual Health HIV (BASHH)\/British HIV Association (BHIVA) guideline review group for the Optimising testing and linkage to care for HIV across Europe (OptTEST) project by HIV in Europeb. HIV Med. 2017;18:300\u20134.","journal-title":"HIV Med."},{"issue":"Suppl 2","key":"3661_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1468-1293.2008.00586.x","volume":"9","author":"JB Wit De","year":"2008","unstructured":"De Wit JB, Adam PC. To test or not to test: psychosocial barriers to HIV testing in high-income countries. HIV Med. 2008;9(Suppl 2):20\u20132.","journal-title":"HIV Med."},{"key":"3661_CR42","volume-title":"Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations","author":"WHO","year":"2014","unstructured":"WHO. Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Geneva: WHO; 2014. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/128048\/1\/9789241507431_eng.pdf?ua=1&ua=1"},{"key":"3661_CR43","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21579","volume":"20","author":"SE Rutstein","year":"2017","unstructured":"Rutstein SE, Ananworanich J, Fidler S, Johnson C, Sanders EJ, Sued O, et al. Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc. 2017;20:21579.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3661-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T19:07:11Z","timestamp":1578337631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3661-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3661"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3661-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Lithuanian Bioethics Committee. The ethics approval number is 158200\u20135\u2013056-10. Consent for HIV screening was incorporated into the patient\u2019s general informed consent for medical care on the same basis as other screening or diagnostic tests, and its written form was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"21"}}